Reviva pharmaceuticals holdings, inc. to participate at the maxim virtual growth conference

Cupertino, calif., march 22, 2022 (globe newswire) -- reviva pharmaceuticals holdings, inc. (nasdaq: rvph) (“reviva” or the “company”), a clinical-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (cns), cardiovascular, metabolic, and inflammatory diseases, today announced that laxminarayan bhat, ph.d., founder, president, and ceo of reviva will participate in a fireside chat and one-on-one investor meetings at the maxim virtual growth conference, to be held march 28-30, 2022. please see additional details below:
RVPH Ratings Summary
RVPH Quant Ranking